Three Essential Takeaways from the FDA’s Latest ESTAR for PMA Submissions
September 24, 2026
Adaptive Trial Design Under the New FDA Framework: Integrating ICH E20, Bayesian Methods, and Trial Innovation
Author
Dr. Mukesh Kumar
Founder & CEO, FDAMap
FDA Purán Newsletter Signup
Subscribe to FDA Purán Newsletter for
Refreshing Outlook on Regulatory Topics
Recent Blogs
Re-Writing Regulation: Will the FDA’s New Rule Actually End Animal Testing?
September 24, 2026
Navigating FDA’s Real-World Biocompatibility Expectations
September 23, 2026
How Large Language Models Uncover Hidden Changes in Clinical Trials
September 17, 2026
Will Artificial Intelligence Create or Eliminate Healthcare Jobs?
September 17, 2026
